The US Food and Drug Administration (#U.S.FDA) (@US_FDA) has expanded its approval of the #Covid19 treatment Veklury, also known as Remdesivir, to include pediatric patients 28 days of age and older weighing at least 3 kilograms who are infected by #SARSCoV2. pic.twitter.com/12Y2qikkeu— IANS (@ians_india) April 25, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


